✦ LIBER ✦

Effects of doxorubicin-containing chemotherapy and a combination withl-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma

✍ Scribed by Raimund Waldner; Claudia Laschan; Alfred Lohninger; Martin Gessner; Heinz Tüchler; Marlies Huemer; Wolfgang Spiegel; Heidrun Karlic

Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 322 KB
Volume: 132
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-005-0054-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of BCG on peripheral blood count

Effects of BCG on peripheral blood counts and drug tolerance of patients with non-Hodgkin lymphoma receiving combination chemotherapy

✍ Brooks, Robert J. ;Jones, Stephen E. ;Gaines, John A. 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

## Abstract Peripheral blood counts and drug dosages were studied in 68 patients with advanced non‐Hodgkin lymphoma, who were assigned at random to receive either chemoimmunotherapy or chemotherapy, in order to determine if Bacillus Calmette Guerin (BCG) immunotherapy lessened myelosuppression or i

Effect of chemotherapy on resting energy

Effect of chemotherapy on resting energy expenditure in patients with non-Hodgkin's lymphoma results of a sequential study

✍ Jacques Delarue; Eric Lerebours; Herve Tilly; Agnes Rimbert; Patrick Hochain; Cl 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 3 views

This study compared the resting energy expenditure (REE) modifications observed during successive intensive identical chemotherapy courses in non-Hodgkin's lymphoma patients to assess indirectly the metabolic changes induced by the cytotoxic effect of drugs on the tumor. With this therapeutic regime

Replacement of conventional doxorubicin

Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors

✍ Christian Johannes Schmitt; Sascha Dietrich; Antony Dick Ho; Mathias Witzens-Har 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 172 KB

Single-dose palonosetron for prevention

Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

✍ Nicola Di Renzo; Antonella Montanini; Donato Mannina; Alessandra Dondi; Stefania 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 141 KB

Early versus late intensification for pa

Early versus late intensification for patients with high-risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation : Five-year results of a randomized trial on behalf of the GOELAMS group

✍ Nina Arakelyan; Christian Berthou; Bernard Desablens; Sophie de Guibert; Vincent 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views